Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEagle Eye Regulatory News (EYE)

Share Price Information for Eagle Eye (EYE)

Share Price is delayed by 15 minutes
Get Live Data
452.50    0.00 (0.00%)
Bid:
445.00
Ask:
460.00
Spread: 15.00 (3.371%)
Market Cap: £136.00m
EYE Live PriceLast checked at - London Stock Exchange

Intraday Eagle Eye Share Chart

Grant of share options

20 Nov 2025 17:47

RNS Number : 4430I
Eagle Eye Solutions Group PLC
20 November 2025
 

20 November 2025

 

Eagle Eye Solutions Group plc

("Eagle Eye" or the "Company")

 

Grant of share options

 

Eagle Eye, a leading SaaS and AI technology company that creates digital connections enabling personalised, real-time marketing at scale announces that the following options over ordinary shares of 1p each in Eagle Eye ("Ordinary Shares") were granted on 20 November 2025 to the following Executive Directors and person discharging managerial responsibilities ("PDMRs") of Eagle Eye for nil cost as follows:

 

Director/PDMR

Role

Number of Ordinary Shares subject to option grant

Total number of Ordinary Shares under option post grants

Total as % of existing issued share capital

Tim Mason

Chief Executive Officer

183,821

2,011,246

6.7%

Lucy Sharman-Munday

Chief Financial Officer

108,547

762,072

2.5%

Al Henderson

Chief Partnership Officer

60,142

144,092

0.5%

James Esson

Company Secretary

39,795

86,159

0.3%

Zyed Jamoussi

Chief Technology Officer

84,746

143,507

0.5%

Cédric Chereau

Managing Director, EagleAI

62,124

120,885

0.4%

Jeff Baskin

Chief Revenue Officer

71,406

71,406

0.2%

 

Annual grant of share options

The awards have been made under the Eagle Eye Solutions Group plc Long Term Incentive Plan scheme with an exercise price of 1p per Ordinary Share. The awards have been granted under the current year's Long Term Incentive Plan performance criteria, vesting following completion of the three-year period ending 30 June 2028 subject to revenue and EBITDA performance criteria and the overall underlying performance of the Company. Consistent with previous awards, the number of options which vest will vary depending on the level of achievement between threshold (revenue £59.9m, EBITDA £12.95m), target and stretch (revenue £74.4m, EBITDA £18.1m) performance levels. In addition, up to 13,473 of the options granted to Cédric Chereau above will vest dependant on the level of achievement of EagleAI between threshold (revenue £9.85m, EBITDA £2.7m), target and stretch (revenue £11.75m, EBITDA £3.5m) performance levels.

 

Following the new grant of options and assuming all vesting criteria are met, the fully diluted number of Ordinary Shares would be 34,264,470; of which the total number of Ordinary Shares over which options currently issued and outstanding represent 12.5% of the fully diluted number of Ordinary Shares. This is in accordance with the Company's shareholder approved limit for shares outstanding under the Company's share option schemes at any time of a maximum of 20% of the ordinary share capital of the Company in issue at such time.

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

 

 

Name

1. Tim Mason

2. Lucy Sharman-Munday

3. Al Henderson

4. James Esson

5. Zyed Jamoussi

6. Cédric Chereau

7. Jeff Baskin

2

Reason for the notification

a)

 

 

Position/status

1. Chief Executive Officer

2. Chief Financial Officer

3. Chief Partnership Officer

4. Company Secretary

5. Chief Technology Officer

6. Managing Director, EagleAI

7. Chief Revenue Officer

b)

Initial notification/Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Eagle Eye Solutions Group plc

b)

LEI

2138002S1AIBVVMZ7A21

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

 

 

Options over Ordinary Shares of 1p each

 

GB00BKF1YD83

b)

Nature of transaction

Grant of Options over Ordinary Shares pursuant to Eagle Eye Solutions Group plc Long Term Incentive Plan

 

c)

Price(s) and volume(s)

Price(s)

Volume(s)

1. Nil

2. Nil

3. Nil

4. Nil

5. Nil

6. Nil

7. Nil

 

1. 183,821

2. 108,547

3. 60,142

4. 39,795

5. 84.746

6. 62,124

7. 71,406

Aggregated information

- Aggregated volume

- Price

 

Not applicable

e)

Date of the transaction

20 November 2025

f)

Place of the transaction

Outside of a trading venue

 

Enquiries:

Eagle Eye Solutions Group plc

Tel: 0844 824 3686

Tim Mason, Chief Executive Officer

Lucy Sharman-Munday, Chief Financial Officer

Investec Bank plc (Nominated Adviser and Joint Broker)

Tel: +44 20 7597 5970

David Anderson / Nick Prowting / James Smith

Shore Capital (Joint Broker)

Tel: +44 20 7408 4090

Corporate Advisory: Daniel Bush, David Coaten, Lucy Bowden

Corporate Broking: Henry Willcocks

 

Alma Strategic Communications

Tel: +44 20 3405 0205

Caroline Forde, Hannah Campbell, Kinvara Verdon

 

 

About Eagle Eye

Eagle Eye is a leading SaaS and AI company, enabling retail, travel and hospitality brands to earn lasting customer loyalty through harnessing the power of real-time, omnichannel and personalized marketing. Our powerful technology combines the world's most flexible and scalable loyalty and promotions capability with cutting edge, built-for-purpose AI to deliver 1:1 personalization at scale for enterprise businesses, globally.

 

Our growing customer base includes Loblaws, Southeastern Grocers, Giant Eagle, Asda, Tesco, Morrisons, JD Sports, E.Leclerc, Carrefour, the Woolworths Group and many more. Each week, more than 1 billion personalized offers are seamlessly executed via our platform, and over 700 million loyalty member wallets are managed worldwide. 

 

AI-powered, API-based and cloud-native, Eagle Eye's enterprise-grade technology is fully certified by the MACH Alliance and has received recognition from leading industry bodies, including Gartner, Forrester, IDC and QKS. 

Web - www.eagleeye.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEURSBRVVUAUAA
Date   Source Headline
28th May 20267:00 amRNSSale of shares from treasury
21st May 20262:47 pmRNSPDMR shareholding & issue of equity - replacement
21st May 20261:35 pmRNSPDMR shareholding and issue of equity
21st May 20267:00 amRNSCapital Markets Day
27th Apr 20267:00 amRNSNotice of Capital Markets Day
24th Apr 202612:30 pmRNSPDMR Shareholding
23rd Apr 20268:11 amRNSPDMR shareholding and issue of equity
31st Mar 20262:02 pmRNSPCA Shareholding
20th Mar 202610:36 amRNSDirector/PDMR Shareholding
17th Mar 202612:11 pmRNSIssue of Equity
17th Mar 20267:00 amRNSHalf Year Results
17th Mar 20267:00 amRNSHalf Year Results
6th Mar 20267:00 amRNSTransaction in Own Shares & Programme Completion
5th Mar 20267:00 amRNSTransaction in Own Shares
4th Mar 20267:00 amRNSTransaction in Own Shares
3rd Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 20265:18 pmRNSNotification of major holdings
2nd Mar 20262:43 pmRNSHolding(s) in Company
2nd Mar 20267:00 amRNSTransaction in Own Shares
27th Feb 20267:00 amRNSTransaction in Own Shares
26th Feb 20267:00 amRNSTransaction in Own Shares
25th Feb 20267:00 amRNSTransaction in Own Shares
24th Feb 20267:00 amRNSTransaction in Own Shares
20th Feb 20267:00 amRNSTransaction in Own Shares
18th Feb 20267:00 amRNSTransaction in Own Shares
12th Feb 20263:32 pmRNSDirector/PDMR Shareholding
12th Feb 202610:59 amRNSDirector/PDMR Shareholding
12th Feb 20267:00 amRNSTransaction in Own Shares
11th Feb 20267:00 amRNSTransaction in Own Shares
10th Feb 20267:00 amRNSTransaction in Own Shares
9th Feb 20267:00 amRNSTransaction in Own Shares
6th Feb 20267:00 amRNSTransaction in Own Shares
5th Feb 20267:00 amRNSTransaction in Own Shares
4th Feb 20267:00 amRNSTransaction in Own Shares
3rd Feb 20267:00 amRNSTransaction in Own Shares
2nd Feb 20267:00 amRNSExtension of Share Buyback Long Stop Expiry Date
29th Jan 20267:00 amRNSTransaction in Own Shares
26th Jan 20267:00 amRNSAppointment of Nominated Adviser and Joint Broker
23rd Jan 20263:48 pmRNSDirector Declaration Update
20th Jan 20267:00 amRNSH1 FY26 Trading Update and Notice of Results
20th Jan 20267:00 amRNSTransaction in Own Shares
19th Jan 20267:00 amRNSTransaction in Own Shares
13th Jan 20267:00 amRNSMajor US multi-year contract win
12th Jan 20267:00 amRNSTransaction in Own Shares
8th Jan 20267:00 amRNSTransaction in Own Shares
31st Dec 20257:00 amRNSTransaction in Own Shares
31st Dec 20257:00 amRNSTransaction in Own Shares
29th Dec 20257:00 amRNSTransaction in Own Shares
29th Dec 20257:00 amRNSTransaction in Own Shares
19th Dec 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.